Anagenics Limited (ASX:AN1)

Market Cap	6.90M +178.0%
Revenue (ttm)	4.83M -35.6%
Net Income	-645.06K
EPS	-0.00
Shares Out	985.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,157,692
Open	0.0060
Previous Close	0.0070
Day's Range	0.0060 - 0.0070
52-Week Range	0.0040 - 0.0090
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Anagenics

Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incor...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2004
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AN1

Financial Performance

In fiscal year 2025, Anagenics's revenue was 5.12 million, a decrease of -52.62% compared to the previous year's 10.80 million. Losses were -1.24 million, -83.51% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 11, 2026

Data Sources Report a data error